Do Not Forget Glycomics and Theranostics for COVID-19 Drug and Vaccine Development

Abstract

View all access options for this article.

Hou

, Yang

, Liu

, et al. (2021). Profile of immunoglobulin G N-glycome in COVID-19 patients: A case–control study. Front Immunol, 12, 748566.

Lardone

, Garay

, Parodi

, et al. (2021). How glycobiology can help us treat and beat the COVID-19 pandemic. JBC, 296, 100375.

Wang

. (2022). Glycomedicine: The current state of the art. Engineering, 15, 327–347.

Wang

, Zhong

, and Wang

. (2021). COVID-19 and preparing planetary health for future ecological crises: Hopes from glycomics for vaccine innovation. OMICS, 25, 234–241.

Wardzala

, Wood

, Belnap

, et al. (2022). Mucins inhibit coronavirus infection in a glycan-dependent manner. ACS Cent Sci, 8, 351–360.